SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Harris EN. Syndrome of the black swan. Br J Rheumatol 1987; 26:3246.
  • 2
    Alving CR. Antibodies to lipids and membranes: reactions with phosphatidylcholine. cholesterol, liposomcs and bromelin-treated erythrocytes. HarrisEN, ExnerT, HughesGRV, AshersonRA, eds. In: Phospholipid binding antibodies. Boca Raton : CRC Press 1991:7395.
  • 3
    Fowler E, Allen PH. Studies on the production of Wasserman reagin. J Immunol 1963; 88:591609.
  • 4
    Inoue KS. Nojima. Immunochemical studies of phospholipids I. Reactivity of various synthetic derivatives with Wasserman antibody. Chem Phys Lipids 1967; 1:3607.
  • 5
    Rauch J, Janoff AS. Phospholipid in the hexagonal II phase is immunogenic evidence for immunorecognition of non-bilayer lipid phase in vivo. Proc Natal Acad Sci USA 1990; 87:41124.
  • 6
    Schuster BG, Neidig M, Alving BM, Alving CR. Producing antibodies to phosphocholine, phosphatidylcholine. and sphinogomyelin and lipid A by injection of liposomes containing lipid A. J Immunol 1979; 122:9005.
  • 7
    Igarashi K, Umeda M, Tokita L, Soo Nam K, Inoue K. Effective induction of antiphospholipid and anticoagulant antibodies in normal mouse. Thromb Res 1991; 61:13548.
  • 8
    Gharavi AE, Sammaritano LR, Wen J, Elkon KB. Induction of antiphospholipid autoantibodies by immunization with β2glycoprotein 1. J Clin Invest 1992; 90:11059.
  • 9
    Polz E, Wurm H, Kostner GM. Investigatior of β2glycoprotein I in rat: isolation from serum and demonstration in lipoprotein density fractions. Int J Biochem 1980; 11:26570.
  • 10
    Pierangeli SS, Harris EN, Davis SA, DeLorenzo G. β2glycoprotein (β2GPl) enhances cardiolipin binding activity but is not the target antigen for antiphospholipid antibodies. Br J Haematol 1992; 82:56570.
  • 11
    Harris EN. Annotation: antiphospholipid antibodies. Br J Haematol 1990; 74:19.
  • 12
    Sammaritano LR, Lockshin MD, Gharavi AE. Antiphospholipid antibodies differ in a PL cofactor requiremenl. Lupus 1992; 1:5156.
  • 13
    Bakimer R, Fishman P, Blank M, Sredni B. Djaidetti M, Shoenfeld Y. Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3). J Clin Invest 1992; 89:15563.
  • 14
    Blank M, Cohen J, Toder V, Shoenfeld Y. Induction of antiphospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anticardiolipin antibodies. Proc Natl Acad Sci USA 1991; 88:306973.
  • 15
    Wurm H. β2glycoprotein 1 (apolipoprotein H) interactions with phospholipid vesicles. Int J Biochem 1984; 16:5115.
  • 16
    Harris EN, Gharavi AE, Tincani A et al. Affinity-purified anticardiolipin and anti-DNA antibodies. J Clin Lab Immunol 1985; 17:15561.
  • 17
    Harris EN, Gharavi AE, Loizou S et al. Cross-reactivity of antiphospholipid antibodies. J Clin Lab Immunol 1985; 16:16.1.
  • 18
    Eilat D, Zlotnick AY, Fischel R. Evaluation of the crossreaction between antiDNA and anti-cardiolipin antibodies in SLE and experimental animals. Clin Exp Immunol 1986; 65:26975.
  • 19
    Havel RJ, Goldstein JL, Brown MS. Lipoproteins and lipid transport. BondyPK, RosenbergLE, eds. In Metabolic control and disease, 8th edn. Philadelphia : WB Saunders 1980:32340.
  • 20
    Shen BW, Scanu AM, Kezdy FJ. Strucure of human serum lipoproteins inferred from compositional analysis. Proc Natl Acad Sci USA 1977; 74:83741.